Starpharma Hldgs ADR (SPHRY) 6.5335 $SPHRY Dendrimers

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Starpharma Hldgs ADR (SPHRY) 6.5335 $SPHRY

Dendrimers Coming Of Age: Starpharma's Star Is Rising
Keith Williams - at Seeking Alpha - Fri May 15, 11:05AM CDT

PFE: 33.99 (+0.05), AZN: 69.29 (-0.81), LLY: 72.90 (-0.16), SNY: 50.52 (-0.27)

Starpharma Holdings Limited CEO Dr. Jackie Fairley to Be Interviewed Live on iHeart Radio/ Clear Channel Atlanta Studios - 640 WGST AM's "Health Tech Talk Live" on February 14, 2015
Marketwired - Fri Feb 13, 6:15AM CST
Starpharma Holdings Limited (ASX: SPL) (OTCQX: SPHRY), a company that researches, develops, and commercializes dendrimer products for pharmaceutical, life-science, and agrochemical applications announced today that Chief Executive Officer (CEO), Dr. Jackie Fairley will be interviewed live on iHeart Radio's Health Tech Talk Live hosted by Ben Chodor and broadcast nationwide on iHeart Radio/ Clear Channel Atlanta Studios - 640 WGST AM this Saturday at 3:00pm ET. In this exclusive double-segment interview, Dr. Fairley will discuss VivaGel(R), the company's development of the world's first antiviral condom (the VivaGel(R) condom) which was recently launched in Australia by Starpharma's partner, Ansell. Dr Fairley will also talk about Starpharma's current US Phase III clinical trials of VivaGel(R) for the prevention of recurrent bacterial Vaginosis as well as its development of the clinical trial of the company's improved version of cancer drug docetaxel (Taxotere). The Company's product, DEP(TM) docetaxel is a dendrimer-enhanced nanoparticle formulation which is currently in a Phase I clinical trial in cancer patients. DEP(TM) docetaxel has shown a number of benefits compared to the commercial version of docetaxel, Taxotere(R) and this platform delivery technology can be used to improve other pharmaceuticals as well. Starpharma also applies its proprietary dendrimers to improve the performance of agrochemical products such as glyphosate (the active ingredient in Roundup(R)) and has a series of partnerships with leading industry players. Shareholders, analysts, industry professionals and all interested parties are encouraged to listen live via Clear Channel's nationally syndicated iHeart Radio stream.
ANN: 38.71 (+0.51)

Starpharma: VivaGel(R) Condom Receives TGA Device Certification - Launch Preparations to Follow
Business Wire - Sun Jul 20, 10:05PM CDT
Starpharma (ASX:SPL) (OTCQX:SPHRY) today announced achievement of a major milestone with the receipt of Conformity Assessment Certification for the VivaGel(R) condom by the Australian Therapeutic Goods Administration (TGA). This TGA certification is similar to CE certification of devices (CE Mark) in Europe.
ANN: 38.71 (+0.51)

FDA Grants Special Protocol Assessment (SPA) Agreement for Starpharma Phase 3 Recurrent BV Trial
Business Wire - Mon Jul 14, 4:35AM CDT
Starpharma Holdings Ltd (ASX:SPL) (OTCQX:SPHRY) today announced that the US Food and Drug Administration (FDA) has granted Special Protocol Assessment (SPA) agreement on the design and planned analyses of the phase 3 clinical studies of the VivaGel(R) bacterial vaginosis (BV) product for the prevention of recurrent BV.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

A Decade of Giving: Light the World Initiative's Impact

Updated Category News Views 53

The Red Kiosk Revolution It's not every day that a church initiative pops up in global conversations, but here we are—ten years into the Light the World initiative by The Church of Jesus Christ of Latter-day Saints. What's interesting is how these little kiosks, like silent ambassadors, have become a staple in 145 spots this holiday season, spanning continents. Each...

Continue Reading
Scribd’s First Safety Report Shows Enforcement at Scale

Updated Category News Views 141

Forty-seven million enforcement actions is not a decorative statistic Scribd finally put some hard numbers on a problem most document platforms prefer to discuss in foggy corporate language. Its first transparency report, covering January through June 2026, says the company took more than 47 million moderation actions across Scribd and Slideshare. That is a hulking...

Continue Reading
TYYY Liquidation Leaves Holders With a Tight Exit Window

Updated Category News Views 144

A fund can vanish faster than investors can read the fine print, and TYYY is doing exactly that. Exchange Traded Concepts has approved the closure and liquidation of the xETFs TSLA Daily Income ETF, with the fund expected to cease operations and distribute cash on or about November 20, 2026. This is not a debate about whether holders should love or hate Tesla. The product...

Continue Reading
USFM's Disko Deal Waits on Greenland Until March 2027

Updated Category News Views 163

A missing Greenland signature has turned USFM’s grand Disko plan into a calendar problem. Nothing more dramatic has been disclosed, but nothing less consequential should be assumed either. March 31 replaces a deadline that already failed USFM executed its share purchase agreement with 80 Mile PLC and Disko Exploration Limited on May 8, 2026. The proposed bargain is...

Continue Reading
Kobo and CloudLibrary Make Library Ebooks Much Easier

Updated Category News Views 107

A tiny button can change whether a digital service gets used Borrowing an ebook ought not feel like assembling a radio in a dark garage, yet that is roughly where library reading has landed for plenty of people. OCLC's new CloudLibrary integration with Kobo strips out a particularly annoying step: U.S. and Canadian users can link accounts once, borrow a title, and have it...

Continue Reading
Paratus on the Move: Seagems JV Under the Microscope

Updated Category News Views 82

What's Cooking with Paratus Energy? Paratus Energy Services Ltd. (ticker: PLSV) just threw us a curveball, announcing a strategic review of its participation in the Seagems joint venture. Now, before you get too jazzed about ticker talk—hold your horses. No one's making any promises about transactions just yet. The decision's still hanging in the balance, even as they...

Continue Reading
TIER IV Simplifies Autonomous Driving with CARLA 1.0

Updated Category News Views 38

No More Detours in Autonomous Development Ever messed with a puzzle that just won't fit until suddenly, it clicks? That's what TIER IV just pulled off with their latest work on CARLA 1.0, the open-source simulator. There's no more mucking about with that separate Python-based bridge to get things communicating—now we're talking native Autoware support. A direct line to...

Continue Reading
Navan’s Travel Survey Sells Friction as a Business Case

Updated Category News Views 154

A forgotten charger can turn a routine trip into a small mutiny. That is the useful little truth sitting underneath Navan’s new survey of 2,000 Americans who travel for leisure or business. The company is poking at the annoyances people carry from the bedroom packing pile to the jet bridge: forgotten items, rushed airport arrivals, pre-flight drinks, chatty strangers,...

Continue Reading
Thoughts Unleashed Arrives With a Personal American Voice

Updated Category News Views 114

A lifetime of observation finally gets its own page Forty is an unusual age to begin writing poetry, which is exactly why Joyce Ann Grooms McGeehan's debut has a little more texture than the usual polished promise of inspiration. Thoughts Unleashed by an Independent, American Woman comes from someone who spent decades teaching French, English, and ESL, then retired to a...

Continue Reading
Red Cat Stock Drama: Revenue Targets and Legal Waves

Updated Category News Views 91

Red Cat's Revenue Predictions Crash and Burn Sitting there on August 6, 2026, Red Cat Holdings had everyone believing they were on a fast track to hitting a hefty revenue target: $150–$180 million for FY2026. CEO Jeffrey Thompson didn't mince words, boasting confidence like a captain before a storm. Fast forward three months, and they're waving the white flag, tossing...

Continue Reading

Top 5 Most Recently Viewed Articles

Rogers 5G Network Achieves Top Reliability Rankings in Canada

Updated Category News Views 293

Rogers Communications Recognition for 5G Reliability Rogers Communications has recently achieved a significant milestone, being recognized as the most reliable 5G wireless network in the country. This recognition comes from umlaut, a respected global leader in independent benchmarking. With this award, Rogers reaffirms its commitment to providing exceptional network...

Continue Reading
Cable Insurance Partners with TruckerCloud for Telematics Growth

Updated Category News Views 179

Cable Insurance Partners with TruckerCloud for Telematics Growth Cable Insurance, known for its commitment to commercial auto insurance, has formed a strategic alliance with TruckerCloud, a prominent telematics provider. This partnership is set to revolutionize Cable's telematics efforts, focusing on integrating real-time driving insights, streamlining claims processes,...

Continue Reading
Osisko Development Secures $24.2 Million in Funding via Placement

Updated Category News Views 256

Osisko Development’s Major Funding Achievement Osisko Development Corp. is thrilled to report the successful completion of the first tranche of its non-brokered private placement. This strategic move has garnered approximately US$24.2 million through the issuance of 13,426,589 units at a price of US$1.80 per unit. These funds mark a significant advancement for the...

Continue Reading
Anywhere Real Estate Inc. Celebrates 14 Years of Ethics in Business

Updated Category News Views 167

Anywhere Real Estate Inc. Recognized for Ethical Leadership Anywhere Real Estate Inc. (NYSE: HOUS), a leader in residential real estate services, proudly announced its recognition as one of the 2025 World’s Most Ethical Companies for the 14th consecutive year. This accolade highlights the company’s unwavering commitment to ethical practices, setting it apart in an...

Continue Reading
Stifel Affirms Buy Rating for STAAR Surgical Amid Market Challenges

Updated Category News Views 78

Stifel Affirms Strong Support for STAAR Surgical Recently, Stifel renewed its Buy rating for STAAR Surgical (NASDAQ:STAA), setting a target price of $44.00 per share. This upbeat assessment comes even amid broader market challenges. By analyzing various data points from China's refractive sector, Stifel suggests that the second half of 2024 could show signs of recovery...

Continue Reading